Figure 4
Figure 4. Negative impact on OS and on the cumulative incidence of AML transformation of BCOR truncating mutations in MDS patients. (A) Kaplan-Meier curve for OS and (B) cumulative incidence of AML transformation according to BCOR mutation status (Fine & Gray test). (C) Univariate and multivariate analyses for OS in MDS patients.

Negative impact on OS and on the cumulative incidence of AML transformation of BCOR truncating mutations in MDS patients. (A) Kaplan-Meier curve for OS and (B) cumulative incidence of AML transformation according to BCOR mutation status (Fine & Gray test). (C) Univariate and multivariate analyses for OS in MDS patients.

Close Modal

or Create an Account

Close Modal
Close Modal